Stay updated on Ertugliflozin in Pediatric T2DM Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.

Latest updates to the Ertugliflozin in Pediatric T2DM Clinical Trial page
- Check3 days agoChange DetectedThe record history page now indicates a newer ClinicalTrials.gov site revision (v3.5.3) rather than the prior revision (v3.5.2), reflecting a technical update to the website itself.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedA new revision entry v3.5.0 was added to the history, and the v3.4.3 entry was removed from the list.SummaryDifference0.0%

- Check46 days agoChange DetectedThe record history now includes a new revision entry v3.4.3, replacing v3.4.2.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.4.2 to the version history; removed the government funding notice and Revision: v3.4.1 from the history.SummaryDifference0.2%

- Check82 days agoChange DetectedAdded a notice about government funding lapse and operating status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Ertugliflozin in Pediatric T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.